Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke — Stephanie L. Harrison (2023) | RDL Network
Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke
Article 2023 en
Authors
SH
Stephanie L. Harrison
BB
Benjamin J. R. Buckley
DL
Deirdre A. Lane
Abstract
1 min read
The results suggest for patients with AF and carotid artery disease after ischaemic stroke, receiving NOACs without APA is associated with a lower risk of major bleeding with no negative impact on recurrent stroke or mortality. Evidence from randomised trials is needed to confirm this finding.
Sandra Elsheikh, Muath Alobaida, Tommaso Bucci, Benjamin J. R. Buckley, Dhiraj Gupta, Greg Irving, Andrew Hill, Professor Gregory Lip, Azmil H. Abdul‐Rahim
Discussion(0)
No comments yet. Be the first to comment.